4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-16-049542
Options or other derivatives
- Chief Financial Officer acquired 198,853 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jeong Tae Heum · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-28 | Grant or award : show line 1 in the form Stock Option (right to buy) | +98,853 | $0.35 | 2026-01-28 | 98,853 | 98,853 | D |
| 2016-01-28 | Grant or award : show line 2 in the form Stock Option (right to buy) | +100,000 | $0.35 | 2026-01-28 | 100,000 | 100,000 | D |
Loading xslF345X03/doc1.xml…